Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Esophageal Neoplasms × Drug Therapy × Clear all

Phase

Status

Completed 10 Recruiting 9 Unknown 6 Not yet recruiting 3 Active not recruiting 2 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 6 Colorectal Neoplasms 4 Recurrence 3 Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasms, Plasma Cell 2 Multiple Myeloma 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Burkitt Lymphoma 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Spinal Cord Neoplasms 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Optic Nerve Glioma 1 Neuroblastoma 1 Neoplasms 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1

Interventions

Radiotherapy 3 Paclitaxel 3 Fluorouracil 3 nimotuzumab 2 Taxes 2 S 1 (combination) 2 Radiation 2 Oxaliplatin 2 Nivolumab 2 Ferrosoferric Oxide 2 Cisplatin 2 Cetuximab 2 Carboplatin 2 pembrolizumab 1 entinostat 1 apatinib 1 Watchful Waiting 1 Trastuzumab 1 TH 302 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Radiotherapy, Intensity-Modulated 1 Polymerase Chain Reaction 1 Observation 1 Nimodipine 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Ipilimumab 1 Immunotherapy 1 Gene Expression Profiling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05245760 2022-11-08

CRATER

University of Kentucky

Phase 2 Withdrawn

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡